Greenstone Healthcare Solutions, the Kalamazoo, MI-based disease management subsidiary of Pharmacia & Upjohn, launched a free, confidential health-risk assessment on the World Wide Web.
Greenstone Healthcare Solutions, the Kalamazoo, MI-based disease management subsidiary of Pharmacia & Upjohn, launched a free, confidential health-risk assessment on the World Wide Web.
The You First⢠Health Risk Assessment uses a browser's answers to questions about family history, health habits and lifestyle behaviors to create a personal report that includes recommendations to improve health and minimize potential problems. Through statistical analysis, a person's lifestyle risks, such as smoking, obesity and not wearing seat belts, are evaluated against documented outcomes associated with those risks.
Respondents receive a report that uses charts and graphs to depict their overall health risk along a continuum from "very low" risk to "very high." The questionnaire takes about five minutes to complete and is located at http://www.youfirst.com.
Greenstone will customize access to its health risk assessment for MultiPlan Inc., a preferred provider organization with more than 20 million lives in the United States. The company also plans to sell the product as an on-line product or in printed format to other organizations.
Information on Greenstone and disease management is located at the company's Web site at http://www.ghsnet.com. PR
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.